Shanel Bhagwandin, DO, FACS,MPH, Medical Director Gastrointestinal Surgical Oncology Program

Primary Specialties:
  • General Surgery  (Board Certified)
  • Surgical Oncology Gastroenterology (GI)  (Board Certified)
  • Hepato-pancreato-biliary(HPB) Surgery  (Board Certified)
561-741-5570
Accepting New Patients
Insurance Accepted:
  • Corvel Workers' Compensation
  • TriCare
  • United Healthcare
  • Beech Street
  • Medicare
  • Multiplan/ PHCS
  • Cigna
  • Aetna
  • Humana
  • Coventry
  • BCBS of Florida
Please call the physician’s office for current insurance information regarding your plan

Primary Office

Jupiter Medical Center Physician Group

1240 S. Old Dixie Hwy., Floor 2, Jupiter, FL 33458

Phone: 561-741-5570

Fax: 561-741-5574

Get Directions

  • About

    About

    About the Physician

    Languages Spoken
    (in addition to English)
    Spanish

    Physician Bio

    Dr Bhagwandin is the Medical Director for the Gastrointestinal (GI) Surgical Oncology Program and Program Director of the National Pancreas Foundation Pancreatic Cancer Center of Excellence at Jupiter Medical Center.

    He utilizes the most recent advances in technology to diagnose and treat benign conditions and a wide array of cancers, including highly complex or recurrent cases:

    • Bile Duct Cancer
    • Colon and Rectal Cancer
    • Esophageal Cancer
    • Gallbladder Cancer
    • Liver Cancer and Colorectal Liver Metastases
    • Neuroendocrine Tumors
    • Pancreatic Cancer
    • Peritoneal Surface Malignancies
    • Skin Cancer
    • Soft Tissue Sarcoma
    • Stomach Cancer

    As a hepatobiliary surgeon, Dr. Bhagwandin also has expertise in the management and treatment of benign conditions, such as:

    • Benign Abdominal Tumors
    • Bile Duct Injuries
    • Biliary Cysts
    • Hepatic Cysts
    • Pancreatic Cysts
    • Splenectomy

    Dr. Bhagwandin is a fellowship trained surgical oncologist and board certified general surgeon. His clinical and research interests include the diagnosis and treatment of complex malignancies of the liver, pancreas, and biliary tract, in addition to gastric and esophageal cancer, colon and rectal cancer, sarcoma, and melanoma. He delivers compassionate care with the goal of restoring patient well-being.

    He specializes in the management of advanced peritoneal carcinomatosis through the application of Hyperthermic IntraPeritoneal Chemotherapy (HIPEC) and cytoreductive surgery; a technique that combines surgery with chemotherapy delivered directly into the abdomen.

    Areas of Interest

    Dr. Bhagwandin's clinical and research interests include the diagnosis and treatment of complex malignancies of the liver, pancreas, and biliary tract, in addition to gastric and esophageal cancer, colon and rectal cancer, sarcoma, and melanoma.

  • Education

    Education

    Medical School:

    Lake Erie College of Osteopathic Medicine

    Internship:

    The Icahn School of Medicine at Mount Sinai

    Residency:

    The University of Illinois Hospital & Health Sciences System

    Fellowship:

    Complex General Surgical Oncology - The Icahn School of Medicine at Mount Sinai

    Board Certification:

    American Board of Surgery -- General Surgery; American Board of Surgery -- Complex General Surgical Oncology
  • In The News

    In The News

    An inspiring update on pancreatic cancer surgery

    GETTING A SECOND OPINION by a Cancer Surgeon

    Specialized treatment of peritoneal mesothelioma cancer

    Dr. Shanel Bhagwandin is changing the lives of patients with peritoneal malignancies, including mesothelioma

    PALM BEACH SURGEON BRINGS SPECIALIZED CANCER TREATMENTS TO THE REGION

    Cancer treatment available at Jupiter Medical Center, featured on "The Good Doctor'

  • Research & Publications

    Research & Publications

    • "Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience." Y. Feferman, D. Solomon, S. Bhagwandin, et al. Annals of surgical oncology 26.2 (2019): 482-489.
    • Malignant peritoneal mesothelioma: a review. J. Kim, S. Bhagwandin, and D. Labow. Annals of translational medicine, 5(11) (2017).
    • "The Important Role of Health Care Alliances in Improving Strategies for Cancer Prevention Protocols." S. Bhagwandin. Population Health Management (2017).
    • "The Surgical Management of Peritoneal Carcinomatosis of Colorectal Origin." S. Bhagwandin, R. Fouad, D. Labow. Oncology (Williston Park, NY) 30, no. 11 (2016).
    • "Metastatic Carcinoid Tumor Presenting as a Breast Mass: A Case Report and Review of the Literature." Ahn, S., S. Bhagwandin, B. Reindl, S. Jaffer, and N. Bickell. Arch Surg Oncol 2, no.111 (2016):2.
    • "Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival." S. Naffouje, R. Naffouje, S. Bhagwandin, and G. Salti. Melanoma Research 25, no. 6 (2015): 496-502.
    • "Utility of Chemoresponse Assay in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy." S. Bhagwandin, S. Naffouje, and G. Salti. Annals of surgical oncology (2015): 1-5.
    • Symptomatic Massive Splenomegaly in Persistent Polyclonal B-cell Lymphocytosis Requiring Splenectomy. S. Bhagwandin, E. Weisenberg, H. Ozer, and A. Maker. Open J Clin Med Case Rep. (2015); 1017
    • "Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge." S. Bhagwandin, S. Naffouje, and G. Salti. Journal of Surgical Oncology 111, no. 3 (2015): 324-327.
    • "Hepatocellular carcinoma with peritoneal metastasis treated with cytoreductivesurgery plus hyperthermic intraperitoneal chemotherapy. S. Bhagwandin and G. Salti " Tumori 101, no. 1 (2014): e1-3.
    • “Acute Appendicitis Confined to an Incisional Hernia Following Renal Transplantation.” S. Bhagwandin, R. Garcia-Roca, H. Jeon. Open Journal of Organ Transplant Surgery, 3, (2013):50.
    • “Pediatric duodenal hematoma: Nonoperative management of blunt traumatic injury.” I E. Jeng, J. Jeng, S. Bhagwandin, G. Merlotti, and J. Doherty. Injury Extra, 44(9), (2013):79-80.
    • "Hyper IgD Syndrome (HIDS) in a Four-Year-Old Boy.” S. Bhagwandin and B. Hostoffer. Journal of American College of Osteopathic Pediatricians, 1 (1). 2008.
    • “Type I Glutaric Aciduria and Combined Immunodeficiencies.” S. Bhagwandin, and B. HostofferJournal of American College of Osteopathic Pediatricians, 1 (2). 2008.

    Book Chapters

    • Abdominal Compartment Syndrome.Lee, JK, Ortiz, D, Bhagwandin, SB, Doherty, J. (2015) In S. Cohn, Acute Care
    • Surgery and Trauma: Evidenced Based Practice (2nd edition) London, UK: CRC Press. December 22, 2015
    • "Complex General Surgical Oncology Fellowship." In A Surgeon's Perspective” Bhagwandin, Shanel B., and Devin C. Flaherty Path, pp. 35-39. Springer, Cham, 2018.
    • Open Cholecystectomy. Chassin's Operative Strategy, Bhagwandin, S and Sarpel, U in General Surgery: An Expositive Atlas (5th edition, in production).

    Abstracts/Presentations

    • “Implementation of a High Risk Pancreatic Cyst Surveillance Program Utilizing 2015 AGA Guidelines.” 2019. S Bhagwandin, DO, MPH. AHPBA 2018 Annual Meeting. (Poster presentation).
    • “Post-fellowship Community Practice Facilitates Early Adoption of Robotic Surgery as Algorithm for Appropriate Patient Selection.”2018. S Bhagwandin, DO, MPH. AHPBA 2018 Annual Meeting. (Poster presentation)
    • “Post-operative AFP Identifies a Subset of Patients at High Risk of Early Recurrence in Hepatitis B-Associated Hepatocellular Carcinoma.” 2017. S Bhagwandin, DO, MPH, Qin Wang, PhD, Wei Luan…Spiros P. Hiotis, MD. AHPBA 2017 Annual Meeting. (Oral presentation)
    • “When Should Reoperative Intervention Be Considered Over Endoscopic Stenting in Patients with Post-Biliary-Enteric Strictures?” 2017. S Bhagwandin, DO, MPH and D Labow, MD. AHPBA 2017 Annual Meeting. (Poster presentation)
    • Perioperative Alpha-feto Protein Response is a Prognostic Marker in Patients with Hepatocellular Carcinoma. 2017 S Bhagwandin, DO, MPH, Q Wang, PhD, and S Hiotis, MD, PhD. Society of Surgical Oncology Cancer Symposium, 2017. (Poster Presentation)
    • "Post pancreaticoduodenectomy anastomotic stricture with recurrent pancreatitis treated with longitudinal pancreaticogastrostomy." 2016. S Bhagwandin, DO, MPH and G. Salti, MD. HPB 18 (2016): e590. (Poster presentation)
    • Repeat Cytoreduction and Hyperthermic Chemotherapy for the Treatment of Recurrent Peritoneal Surface Malignancy. International Symposium on Regional Cancer Therapies, 2016 S Bhagwandin DO, MPH, R Fouad, D. Labow, MD. 2016. (Oral Presentation)
    • Assessment of Pre-operative PCI Scoring with Integrated PETDWI-MRI in Patients with Peritoneal Carcinomatosis: A Feasibility Pilot Study in Development. 2016 S Bhagwandin DO, MPH and D. Labow. MD International Symposium on Regional Cancer Therapies, 2016. (Oral Presentation)
    • The Role of Second-Look Laparoscopy in Patients at Risk of Recurrent Peritoneal Carcinomatosis. 2016 S Bhagwandin DO, MPH and D. Labow, MD. International Symposium on Regional Cancer Therapies, 2016. (Oral Presentation)
    • Evaluation of HIPEC Charges and Payments at a Community Hospital. 2015. C O’Donoghue, MD, MPH, S Bhagwandin DO, MPH, and G. Salti, MD. International Symposium on Regional Cancer Therapies, 2015. (Poster Presentation)
    • Delayed Major Adverse Events Following Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy. 2014 S Bhagwandin, DO, S Naffouje, MD, and G. Salti, MD. 9th International Congress on Peritoneal Surface Malignancies, 2014. (Poster Presentation)
    • Utility of in vitro drug sensitivity inpatients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. 2014 S Bhagwandin, DO, and G. Salti, MD. Resident Research Forum, 2014. (Oral Presentation)
    • Validation of the peritoneal surface disease severity score in patients with Sarcomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy. 2014 S Bhagwandin, DO, S Undevia, MD, and G Salti, MD. International Symposium on Regional Cancer Therapies, 2014. (Poster Presentation)
    • Impact of the Peritoneal Surface Disease Severity Score in Patients with Sarcomatosis Undergoing Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. 2014 S Bhagwandin, DO, S Undevia, MD, and G Salti, MD. Society of Surgical Oncology Cancer Symposium, 2014. (Poster Presentation)
    • PoplitealArtery Pseudoaneurysm Resulting from Osteochondroma of the Femur in a Pediatric Patient.2011 M Habeeb, MD, S Bhagwandin, DO, A Dhadwal, MD, and M Borhani, MD. Midwestern Vascular Society, 2011 (Oral Presentation)
    • Management of Aggressive Digital Papillary Adenocarcinoma: A Rare Sweat Gland Tumor.2009 S Bhagwandin, DO, R Montilla, MD, and D Rothkopf, MD. New England Hand Society, 2009. (Oral Presentation)
    • Type I Glutaric Aciduria and Combined Immunodeficiencies. 2008 S. Bhagwandin, and B. Hostoffer, MD. 2008 American College of Osteopathic Pediatricians Spring Convention: Savannah, GA. April, 2008.(Oral Presentation)
    • Hyper IgD Syndrome in a Four-Year-Old Boy. 2008 S. Bhagwandin, and B. Hostoffer, MD. 2008 American College of Osteopathic Pediatricians Spring Convention: Savannah, GA. April, 2008. (Poster Presentation)